Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Leases (2019 - 2025)

CorMedix's Current Leases history spans 7 years, with the latest figure at $853000.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 407.74% year-over-year to $853000.0; the TTM value through Dec 2025 reached $853000.0, up 407.74%, while the annual FY2025 figure was $853000.0, 407.74% up from the prior year.
  • Current Leases for Q4 2025 was $853000.0 at CorMedix, up from $844431.0 in the prior quarter.
  • Across five years, Current Leases topped out at $853000.0 in Q4 2025 and bottomed at $112323.0 in Q1 2021.
  • The 5-year median for Current Leases is $142533.0 (2023), against an average of $216059.9.
  • The largest annual shift saw Current Leases increased 10.22% in 2022 before it skyrocketed 418.06% in 2025.
  • A 5-year view of Current Leases shows it stood at $121368.0 in 2021, then increased by 11.07% to $134801.0 in 2022, then rose by 8.7% to $146531.0 in 2023, then increased by 14.65% to $168000.0 in 2024, then soared by 407.74% to $853000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Current Leases are $853000.0 (Q4 2025), $844431.0 (Q3 2025), and $177172.0 (Q2 2025).